| Financial Year |
March 31 2023 |
| Monetary Funds |
2,841,351,578.06 |
| Held-for-trading Financial Assets |
112,633,395.00 |
| Notes Receivable |
57,794,930.10 |
| Accounts Receivable |
931,253,486.58 |
| Advances to Suppliers |
115,361,103.53 |
| Other Receivables |
46,810,607.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,161,676,517.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
201,100,735.27 |
| Total Current Assets |
5,555,254,543.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,171,991.16 |
| Investment Properties |
5,020,887.18 |
| Fixed Assetes |
1,535,458,913.69 |
| Under-construction Projects |
1,314,921,467.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
315,369,325.86 |
| R&D expenses |
19,807,086.05 |
| Goodwill |
1,833,119,502.83 |
| Long-Term Deferred and Prepaid Expenses |
42,571,680.94 |
| Deferred Income Tax Assets |
112,752,568.07 |
| Other Non-Current Assets |
322,367,639.84 |
| Sub-Total of Non-Current Assets |
5,625,387,988.38 |
| Total Assets |
11,180,642,531.96 |
| Short-Term Loans |
1,244,853,469.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
47,951,878.00 |
| Accounts Payable |
311,545,981.45 |
| Accounts Received In Advance |
418,408.58 |
| Employee Compensation Payable |
37,903,967.13 |
| Taxes Payable |
148,193,555.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,766,300.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,845,453.26 |
| Other Current Liabilities |
20,174,845.68 |
| Sub-Total of Current Liabilities |
2,533,899,906.79 |
| Long-term Loans |
124,107,604.41 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,478,113.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
261,473,725.40 |
| Total Liabilities |
2,795,373,632.19 |
| Paid-In Capital(Or Share Stock) |
475,927,678.00 |
| Capital Surplus |
4,082,280,015.37 |
| Surplus Reserve |
116,001,074.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,022,923,382.65 |
| Minority Stockholder's Interest |
1,739,307,351.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,645,961,548.27 |
| Owner's Equity（Stockholder's Equity） |
8,385,268,899.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,180,642,531.96 |
